ABSTRACT: Glucose metabolism in five healthy subjects fasted for 16 h was measured with a combination of [U-
INTRODUCTION
In the postabsorptive state, endogenous glucose production (GP) is sustained by a combination of glycogenolysis and gluconeogenesis. These fluxes can now be measured in a standard clinical setting by ingestion of 2 H 2 O [1] [2] [3] [4] followed by an isotope dilution measurement of glucose turnover once plasma glucose 2 H-enrichment from 2 H 2 O has reached steady state. 1, 2, 4 Glucose turnover is obtained by a primed infusion of a non-recyclable glucose tracer such as [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose, 2 or [6, H 2 ]glucose. 1, 4 Enrichment of plasma glucose from both tracers is then resolved and quantified from a single set of blood samples obtained at the end of the glucose turnover measurement. The ratio of 2 H-enrichment in positions 5 and 2 of plasma glucose from ingested 2 H 2 O provides a measure of the fraction of GP derived from gluconeogenesis and glycogenolysis. [1] [2] [3] [4] Meanwhile, the enrichment level of the infused glucose tracer allows glucose turnover and the absolute rate of GP to be estimated. [1] [2] [3] [4] Absolute gluconeogenic flux is thus estimated as the product of absolute GP and the fraction of GP derived from gluconeogenesis, while absolute glycogenolytic flux is the difference between the absolute rates of GP and gluconeogenesis. 1, 2, 4 Mass spectrometry (MS) procedures have been developed for quantifying and resolving plasma glucose enrichment from a mixture of 2 H 2 O and [6,6-2 H 2 ]glucose. 1, 4 While this approach is highly sensitive and utilizes a relatively inexpensive tracer of glucose turnover, the derivatization procedure is laborious and difficult to routinely implement in a clinical laboratory setting. 1, [3] [4] [5] Alternatively, 2 H NMR analysis of a monoacetone glucose derivative (MAG) of plasma glucose 6, 7 is less sensitive but much simpler to perform and provides 2 H enrichment information for all positions of glucose. Note that 2 H NMR cannot resolve deuterium isotopomers of glucose, thereby precluding measurement of GP with [6,6- C isotopomers can be resolved by NMR, allowing GP to be quantified with an alternative 13 C-tracer such as [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose. 2 This approach would be considerably simplified if all 2 H enrichment and 13 C isotopomer information could be obtained from a single MAG derivative. This cannot be accomplished with [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose because spin-spin coupling between carbons 1 and 6 of glucose is abolished following its conversion to MAG. However, MAG features 13 C- 13 C couplings that are favorable for resolving and quantifying a number of other glucose 13 C-isotopomers including [U- 13 C]glucose, a widely used 13 C tracer of GP. Therefore, a principal goal of this study was to administer a combination of This provides estimates of GP and its component fluxes from glycogen and gluconeogenesis from a single NMR sample.
In addition to providing estimates of GP in humans, [U- 13 C]glucose is also a potential hepatic Krebs cycle tracer as a consequence of carbon recycling (glucose ! pyruvate ! glucose) via the Cori and glucose-alanine cycles. Resolution and quantification of glucose triose 13 C-isotopomers formed by recycling has been used to estimate the fractional contribution of gluconeogenesis to GP. 8 However, this measurement is fraught with both physiological and methodological uncertainties [9] [10] [11] [12] [13] 29, 30 The corresponding -ketoglutarate isotopomers generated from condensation of the OAA isotopomers with unlabeled acetyl-CoA are also shown through the hepatic Krebs cycle and gluconeogenic pathways, giving rise to a mixture of phosphoenolpyruvate (PEP) isotopomers which propagate into both triose moieties of plasma glucose (see Fig. 1 ). The 13 C-isotopomer distributions of OAA and other Krebs cycle intermediates are also preserved in the carbon skeletons of aspartate, glutamate and glutamine. This was demonstrated in pigs infused with [U- 13 C]glucose, 14 but to our knowledge it has not been established in humans. Human hepatic glutamine can be safely assayed by ingestion of phenylacetic or phenylbutyric acid, and the 13 C isotopomer distribution of the glutamine moiety characterized by 13 C NMR of urinary phenylacetylglutamine (PAGN). 2, 15 Hepatic glutamine 13 C isotopomer analysis provides a comprehensive assessment of Krebs cycle fluxes that can be integrated with measurements of GP and gluconeogenesis. 2 To determine if hepatic glutamine 13 C-isotopomer information could be obtained in this manner from [U- 13 C]glucose, we supplemented the tracers with oral phenylbutyrate and analyzed urinary PAGN by 13 C NMR.
MATERIALS AND METHODS

Human studies
All subjects were studied with a protocol approved by the University of Coimbra Hospital Ethics Committee and all gave informed consent prior to admission into the study. The group consisted of five healthy subjects, three males and two females with a mean age of 25 AE 7 years (range 19-39 years) and mean weight of 68 AE 10 kg (range 54-78 kg).
Subjects began fasting at 20:00. During the fast, they ingested a quantity of sterile and pyrogen-free 70% 2 H 2 O to attain body water enrichment of $0.5%. For each subject, the amount of 70%-enriched 2 H 2 O required to achieve 0.5% body water enrichment was $260 ml. To reduce the possibility of vertigo, this was divided into two portions of $130 ml, each taken at 01:00 and 06:00 (5 and 10 h into the fast). For the remainder of the study, all subjects ingested 0.5% 2 H 2 O ad libitum. At 08:00 the next day, a 4 h primed infusion of sterile and pyrogenfree [U- 13 C]glucose (4.7 mg/kg prime, $0.060 mg/kg/min) into a peripheral forearm vein was initiated. Subjects ingested 250-500 mg phenylbutyric acid packaged in gelatin capsules at 09:40, 10:00 and 10:20, for a total of 0.75-1.5 g. At 11:00, 11:20, 11:40 and 12:00, 20 ml of blood were drawn from a contralateral vein. Urine was collected from 10:30 to 12:00 after which the study was concluded.
Sampling processing
Blood was stored at 4 C and centrifuged within 2 h of being drawn. For some samples, the plasma supernatant protein was precipitated by centrifugation following addition of one-tenth the plasma volume of 70% perchloric acid. The supernatant was neutralized with KOH and lyophilized following centrifugation of precipitated KClO 4 . For the remaining samples, plasma protein was precipitated by the addition of 4 vols methanol per volume of plasma and the supernatant was recovered by filtration via a Buchner funnel. The methanol was removed by rotary evaporation at 40 C after which the remaining aqueous fraction was removed by lyophilization. For conversion of plasma glucose to the monoacetone derivative, the lyophilized extracts were treated with 3-20 ml anhydrous acetone enriched to 0.15% with acetone-d 6 to which concentrated sulfuric acid (4% v/v) was added. The solution was quickly cooled to room temperature, and MAG was prepared for NMR analysis as described. 16 Urine samples were adjusted to pH 7.0 and incubated overnight with 10000 U of urease per sample. A trace of sodium azide was also added to inhibit possible infection from airborne microorganisms. The samples were then depleted of protein by addition of perchloric acid, followed by neutralization, centrifugation and lyophilization. Upon reconstitution in 2-3 ml water, the pH was adjusted to 8.0, the sample loaded on to a 5 ml Dowex-1 Â 8-acetate column and washed with 25 ml of water. PAGN was eluted with 15 ml of 10 M acetic acid. This fraction was evaporated and re-suspended in 0.5-1.0 ml water. The pH was adjusted to 7.0 with NaOH, and the samples were centrifuged in Eppendorf tubes. A 0.5 ml aliquot of the supernatant was introduced into a 5 mm NMR tube and 100 ml of CD 3 CN were added to provide a deuterium signal for lock and shimming.
NMR spectroscopy
2 H NMR spectra of urine water and MAG were acquired at 11.75 T with a Varian Unity 500 system equipped with a 5 mm broadband 'switchable' probe with z-gradient (Varian, Palo Alto, CA, USA) as described. 17 Absolute enrichment of glucose hydrogen 2 in selected MAG samples was obtained by addition of a 2 H-formate standard of known enrichment to the NMR sample. 16 13 C NMR spectra of MAG were obtained following addition of 100 ml CD 3 CN to provide a lock signal. 13 C NMR spectra of PAGN were obtained following addition of 100 ml CD 3 CN to a neutral, aqueous solution of PAGN in $1.0 ml distilled water and incorporation of 0.6 ml of this mixture into a 5 mm NMR tube. In all cases, partially saturated 13 C NMR spectra were obtained with an acquisition time of 2 s and a pulse delay of 1 s. The number of acquisitions ranged from 5000 to 25000. For some samples, and for MAG prepared from [U- 17 For all plasma glucose samples, MAG carbon 1 13 C-enrichment was quantified from its 13 C NMR spectrum using the approach of Brainard et al. 18 Here, the intensity of the 13 C singlet component of any given glucose resonance is assumed to represent the natural abundance 13 C-enrichment of 1.11%. The intensity of a 13 C-13 C spin-coupled multiplet signal is expressed as fractional 13 C enrichment by obtaining the ratio of the multiplet and singlet signal and multiplying by 1.11%. For example, if a glucose 13 C resonance features a multiplet whose intensity is twice that of the singlet, then the percentage 13 C-enrichment represented by the glucose 13 C-isotopomers that contribute to that multiplet signal will be 2 Â 1.11 ¼ 2.22%. Deuterium enrichment of body water was determined by 2 H NMR analysis of plasma and urine 2 H water enrichment as previously described. 16 Sterile and pyrogen-free [U- 13 C]glucose was obtained from Cambridge Isotopes (Cambridge, MA, USA). Sterile and pyrogen-free 70% 2 H 2 O was obtained from Cambridge Isotopes and Eurisotop, Gif-sur-Yvette, France. All NMR spectra were analyzed using the curve-fitting routine supplied with the NUTS PC-based NMR spectral analysis program (Acorn NMR Inc., Fremont, CA, USA).
Calculations
Total
13 C-enrichment of plasma glucose carbon 1 and enrichment of the [U- 13 C]glucose isotopomer were determined from the carbon 1 multiplet of MAG. The singlet fraction (S) is assumed to be derived from natural abundance 13 C and is assigned an enrichment value of 1.11%. 18 The Q125 signal is assumed to reflect contribution from [U- 
RESULTS AND DISCUSSION
Analysis of glucose isotopomers by 13 C NMR of MAG
13
C NMR spectroscopy of MAG in acetonitrile yields significant advantages for analysis of glucose C coupling with nearest neighbors and also with more distant carbons (see Table 1 ), providing the basis for resolving a diversity of glucose Table 1 ). For MAG prepared from plasma glucose, it is assumed that this quartet represents [U- 13 C]glucose since dilution of the tracer by endogenous substrates is such that the probability of generating glucose molecules enriched in positions 1, 2 and 5 via recycling or from other pathways is negligible. The anticipated glucose triose isotopomers generated by recycling (see Fig. 1 ) generate a doublet signal which is resolved from the quartet assigned to [U- C spin-coupled multiplets in resonances 2-6 of MAG (some of which are discernable in Fig. 2 ) can potentially further resolve and quantify the distribution of glucose triose 13 C-isotopomers. However, under our study conditions, the signal-to-noise ratios of these multiplets were generally too low for reliable quantification. Table 2 ). The relatively low abundance of recycled 13 C is consistent with extensive dilution at several points in the Cori cycle 9 and by unlabeled hepatic precursors of glucose. 13 Estimates of carbon 1 fractional 13 C-enrichment and that of [U- 13 C]glucose are listed in Table 2 . In five selected samples, carbon 1 fractional 13 C-enrichment values obtained by 13 C NMR were identical to those obtained by 1 H NMR analysis (data not shown). This agreement supports the validity of the method of Brainard et al. 18 for measuring fractional 13 C-enrichment directly from the 13 C NMR spectrum under the conditions of our study. From the 13 C NMR data, estimates of GP were obtained (Table 3) , which are in good agreement with recent NMR and MS measurements. 2, 8, 13 Our estimates are also concordant with the study of Brainard et al. 18 Here, plasma glucose was analyzed directly following [U- 13 C]glucose infusion in a single overnight-fasted healthy subject and the contribution of recycled 13 C was not resolved from that of the infused [U- 13 C]glucose. The agreement between our data and that of Brainard et al. is not surprising given the relatively low levels of recycled 13 C isotopomers compared with those of [U- H signal intensities in the glucose hexose skeleton is shown in Fig. 3 . The relative enrichment of hydrogens 2, 5 and 6S of glucose are obtained by quantifying the relative areas of the respective signals in the spectrum. 2, 16, 23 For two of the subjects, derivatization of glucose to MAG was incomplete; hence blood samples were pooled to obtain spectra with acceptable signal-to-noise. For the three remaining subjects, a set of three deuterium spectra were obtained. For each of these subjects, the coefficient of variance associated with the hydrogen 5/hydrogen 2 and hydrogen 6S/hydrogen 2 enrichment ratio measurement was $10%. For the group of five subjects, the enrichment of glucose hydrogen 2 was estimated to be 98 AE 7% that of body water, indicating that all plasma glucose molecules had undergone complete exchange of hydrogen 2 and body water via interconversion of glucose-6-phosphate and fructose-6-phosphate.
Estimation of plasma [U-
1 The relative 2 H-enrichments of positions 2, 5 and 6S and the fractional contribution of glycogen and gluconeogenic substrates to GP calculated from this data are summarized in Table 4 . The data show that at 16 h of fasting, gluconeogenesis accounts for $50% of GP, with anaplerotic outflow from the Krebs cycle contributing the bulk of gluconeogenic flux with only minor contributions from glycerol. These values are in good agreement with recent NMR and MS measurements. 1, 2 The relative rates of gluconeogenesis and glycogenolysis were converted to absolute flux values by multiplication with GP and these absolute flux values are presented in Table 3 .
Under the conditions of this study, estimates of glycerol gluconeogenesis are associated with relatively high 2 H NMR spectrum of MAG prepared from a single plasma glucose blood sample of subject 4. The number above each signal represents its position in the glucose skeleton. The spectrum represents 53 850 free-induction decays for a total collection time of $ 18 h levels of uncertainty (note the range and standard deviation for glycerol gluconeogenesis in Table 3 and 4) . This is partly due to the fact that the fractional contribution of glycerol to GP is obtained by subtraction of two signals of comparable intensities (hydrogen 5 and 6S) that are associated with noise levels of $10%. In addition, some of the difference in 2 H enrichment between hydrogens 5 and 6S of glucose may be due to incomplete exchange of hydrogen between water and gluconeogenic precursors that pass through the Krebs cycle. 2 This results in an overestimate of glycerol gluconeogenesis and a corresponding underestimate of gluconeogenesis from the Krebs cycle. Note that this latter uncertainty cannot be minimized by improving the signal to noise ratio of the 2 H NMR spectrum.
PAGN enrichment and 13
C-isotopomer distributions from [U- 13 
C]glucose
Generally, excess 13 C-enrichment levels in the glutamine carbons of PAGN following [U- 13 C]glucose administration were very low, ranging from 0.1 to 0.2% for carbons 2 and 3 and $0.05% for carbon 4. These enrichment levels were lower than that of the recycled glucose isotopomers indicating incomplete equivalence of 13 Cenrichment between oxaloacetate (OAA) of the hepatic Krebs cycle and the OAA moiety of glutamine. This is probably due to dilution of 13 C-glutamine derived from the hepatic Krebs cycle by the influx of unlabeled glutamine from peripheral tissues. [24] [25] [26] [27] Not surprisingly, the largest multiplet contributions was derived from subject 2, who received the highest infusion rate of [U- 13 C]glucose (0.071 mg/kg/min), and is shown in Fig. 4 . PAGN spectra from the remaining subjects had somewhat lower multiplet intensities. Generally, while individual multiplet components had adequate signal-tonoise ratios (see inset of Fig. 4 ), they were difficult to quantify due their small size in comparison to the large central singlet signal. In particular, they were highly susceptible to minor shimming maladjustments, including artifact signals from spinning sidebands. Furthermore, as a consequence of the very low levels of excess 13 C-enrichment from the tracer, the multiplets contain significant contributions from natural abundance 13 C- 13 C isotopomers, present at $0.011%. For the carbon 2 resonance, these were estimated to account for 10% of the D23, and 25% of the D12 signal while for the carbon 4 resonance, they accounted for 14% of the doublet signal.* Uncorrected, these natural abundance contributions would substantially distort metabolic flux estimates derived from the multiplet intensities. Nevertheless, Fig.  4 demonstrates the potential of obtaining PAGN [U- 13 C]glucose and qualitatively reveals some important characteristics of hepatic Krebs cycle fluxes. In the carbon 2 multiplet, the intensity of the D23 signal clearly exceeds that of the quartet (Q), indicating a substantial excess of [2,3- 13 C 2 ]glutamine over [1, 2, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 3 ]glutamine. This is consistent with extensive cycling of carbons between pyruvate and OAA 19 and is in agreement with the glutamine 13 C-isotopomer distribution following metabolism of [U- 13 C]propionate. 19 The presence of a doublet corresponding to [4, [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glutamine in the carbon 4 signal indicates entry of [U- 13 C]acetyl-CoA into the cycle, presumably from oxidation of [U- 13 C]pyruvate via pyruvate dehydrogenase.
The multiplet information from carbons 2, 3 and 4 of PAGN therefore provide the basis for describing hepatic anaplerotic, oxidative and pyruvate recycling fluxes. This analysis assumes that the 13 C-isotopomer distribution of PAGN is entirely derived from the hepatic Krebs cycle. Since the liver also receives glutamine from peripheral tissues, notably skeletal muscle, the possibility exists that 13 C-enriched glutamine could be produced via peripheral oxidation of [U- 13 C]glucose, then exported to the liver and incorporated into PAGN. This would distort the observed 13 C-isotopomer distribution because anaplerotic and pyruvate recycling activities are much smaller in muscle compared to liver. In principle, the extent of such extra-hepatic contributions can be gauged by comparing the PAGN isotopomer distribution derived from [U- 13 C]glucose with that obtained from a more specific hepatic tracer, such as [U- C]glucose infusion, we anticipate that a doubling of the glucose infusion rates used in this study to $0.12-0.15 mg/kg/min ($3 g of [U- 13 C]glucose per subject) would be sufficient to routinely provide good-quality PAGN isotopomer information by 13 C NMR. Meanwhile, these higher infusion rates would generate plasma [U- 13 C]glucose enrichment levels of 5-6%; sufficiently dilute for estimating GP with the current approach. Additionally, the application of new indirect detection methods such as the J-resolved HSQC procedure 28 would eliminate spinning sideband artifacts while substantially improving the sensitivity of the 13 C-isotopomer measurements.
In summary, we developed a highly practical method for quantifying GP and absolute gluconeogenic and glycogenolytic fluxes by NMR analysis of a single convenient derivative of plasma glucose following administration of [U- 
